PuraPharm Corporation Limited
HKEX:1498.HK
0.66 (HKD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 47.221 | 107.014 | 85.054 | 126.457 | 93.124 | 104.884 | 86.805 | 209.129 | 232.243 | 46.736 | 32.852 |
| Short Term Investments
| 22.849 | 0 | 36.385 | 41.145 | 31.612 | 29.17 | 26.791 | 14.738 | 9.168 | 5.305 | 0 |
| Cash and Short Term Investments
| 42.975 | 107.014 | 85.054 | 126.457 | 93.124 | 134.054 | 113.596 | 223.867 | 241.411 | 52.041 | 32.852 |
| Net Receivables
| 112.881 | 156.127 | 300.039 | 263.579 | 262.346 | 290.657 | 242.603 | 231.689 | 161.018 | 103.098 | 98.744 |
| Inventory
| 175.597 | 190.812 | 199.798 | 190.15 | 210.965 | 259.494 | 300.723 | 167.064 | 107.987 | 89.893 | 65.214 |
| Other Current Assets
| 13.869 | 32.043 | 25.966 | 27.492 | 31.267 | 48.019 | 35.263 | 35.9 | 30.756 | 60.574 | 43.404 |
| Total Current Assets
| 349.568 | 485.996 | 610.857 | 607.678 | 597.702 | 732.224 | 692.185 | 658.52 | 541.172 | 305.606 | 240.214 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 396.905 | 431.077 | 492.063 | 554.436 | 412.909 | 294.676 | 297.059 | 117.383 | 93.713 | 77.729 | 80.694 |
| Goodwill
| 17.944 | 20.993 | 20.993 | 88.339 | 88.339 | 155.685 | 155.685 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 34.744 | 58.633 | 62.055 | 131.259 | 122.614 | 36.19 | 35.175 | 26.47 | 8.939 | 7.134 | 5.222 |
| Goodwill and Intangible Assets
| 52.688 | 79.626 | 83.048 | 219.598 | 210.953 | 191.875 | 190.86 | 26.47 | 8.939 | 7.134 | 5.222 |
| Long Term Investments
| 25.999 | 24.374 | 25.122 | 25.826 | 25.752 | 10.741 | 11.548 | 11.19 | 2.499 | 10.531 | 10.234 |
| Tax Assets
| 8.819 | 11.047 | 10.483 | 11.291 | 12.363 | 16.383 | 16.313 | 12.2 | 6.872 | 5.047 | 0 |
| Other Non-Current Assets
| 9.984 | -15.623 | -15.71 | -44.252 | -37.437 | -27.124 | -16.313 | -12.2 | -6.872 | -5.047 | 11.747 |
| Total Non-Current Assets
| 494.395 | 530.501 | 595.006 | 766.899 | 624.54 | 486.551 | 499.467 | 155.043 | 105.151 | 95.394 | 107.897 |
| Total Assets
| 843.963 | 1,016.497 | 1,205.863 | 1,374.577 | 1,222.242 | 1,333.103 | 1,293.977 | 860.248 | 697.332 | 420.31 | 348.111 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 146.379 | 137.911 | 140.679 | 159.344 | 178.985 | 139.201 | 112.195 | 74.191 | 38.091 | 44.546 | 29.873 |
| Short Term Debt
| 321.995 | 428.645 | 420.91 | 310.731 | 355.312 | 384.028 | 493.744 | 261.048 | 125.431 | 182.692 | 183.343 |
| Tax Payables
| 2.066 | 1.439 | 3.578 | 2.845 | 5.85 | 3.712 | 5.05 | 7.227 | 4.668 | 3.78 | 0 |
| Deferred Revenue
| 2.484 | 6.414 | 10.183 | 9.795 | 14.041 | 7.867 | 5.026 | 2.248 | -125.431 | -182.692 | 0 |
| Other Current Liabilities
| -48.214 | -46.914 | -50.715 | -50.172 | -94.093 | -73.284 | -44.116 | -16.145 | 145.102 | 189.703 | 25.351 |
| Total Current Liabilities
| 571.089 | 665.406 | 665.314 | 591.887 | 639.08 | 600.725 | 684.094 | 402.76 | 225.952 | 282.575 | 268.44 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 81.093 | 48.68 | 91.997 | 178.992 | 143.715 | 148.123 | 54.277 | 0 | 0 | 0 | 4.847 |
| Deferred Revenue Non-Current
| 1.076 | 1.025 | 1.174 | 3.853 | 2.038 | 3.194 | 51.484 | 1.399 | 1.497 | 1.909 | 0 |
| Deferred Tax Liabilities Non-Current
| 1.743 | 3.017 | 2.611 | 3.235 | 2.607 | 2.516 | 2.793 | 1.584 | 0.173 | 0.013 | 0 |
| Other Non-Current Liabilities
| 35.726 | 39.055 | 42.035 | 81.099 | 70.641 | -5.71 | -54.277 | -1.399 | -1.497 | 0 | 1.712 |
| Total Non-Current Liabilities
| 119.638 | 91.777 | 137.817 | 267.179 | 219.001 | 148.123 | 54.277 | 1.584 | 0.173 | 1.922 | 6.559 |
| Total Liabilities
| 690.727 | 757.183 | 803.131 | 859.066 | 858.081 | 770.884 | 744.895 | 405.743 | 227.622 | 284.497 | 274.999 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 306.82 | 306.82 | 306.042 | 306.042 | 204.028 | 191.981 | 191.981 | 174.375 | 174.375 | 30 | 0 |
| Retained Earnings
| -386.511 | -280.449 | -160.538 | -38.505 | -69.697 | 184.393 | 164.121 | 162.232 | 130.07 | 101.612 | 67.149 |
| Accumulated Other Comprehensive Income/Loss
| 14.215 | 13.206 | 38.086 | 29.721 | 10.508 | 14.066 | 21.82 | 0.172 | 17.584 | 4.077 | 5.883 |
| Other Total Stockholders Equity
| 218.712 | 218.712 | 217.968 | 214.4 | 217.284 | 171.779 | 171.16 | 117.726 | 147.681 | 0 | 0 |
| Total Shareholders Equity
| 153.236 | 258.289 | 401.558 | 511.658 | 362.123 | 562.219 | 549.082 | 454.505 | 469.71 | 135.689 | 73.032 |
| Total Equity
| 153.236 | 258.289 | 401.558 | 511.658 | 362.123 | 562.219 | 549.082 | 454.505 | 469.71 | 135.813 | 73.112 |
| Total Liabilities & Shareholders Equity
| 843.963 | 1,016.497 | 1,205.863 | 1,374.577 | 1,222.242 | 1,333.103 | 1,293.977 | 860.248 | 697.332 | 420.31 | 348.111 |